Skip to content

Drug interactions

Human papillomavirus vaccine quadrivalent + Sirolimus

Severity: Moderate

Human papillomavirus vaccine quadrivalent and Sirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Immunosuppression with sirolimus may blunt the antibody response to this inactivated recombinant vaccine, leaving patients less protected. The vaccine is not live and is not harmful in itself.

What this interaction means in plain words

Human papillomavirus vaccine quadrivalent and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Pharmacodynamic antagonism: mTOR inhibition suppresses lymphocyte proliferation and the vaccine immune response.

What to do

Vaccination is still recommended and should not be withheld; ideally complete it before starting immunosuppression. Consider checking the response where relevant.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Human papillomavirus vaccine quadrivalent and Sirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Human papillomavirus vaccine quadrivalent with Sirolimus?

MediHelp rates the interaction as moderate. Human papillomavirus vaccine quadrivalent and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Immunosuppression with sirolimus may blunt the antibody response to this inactivated recombinant vaccine, leaving patients less protected. The vaccine is not live and is not harmful in itself.

How serious is the interaction between Human papillomavirus vaccine quadrivalent and Sirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccination is still recommended and should not be withheld; ideally complete it before starting immunosuppression. Consider checking the response where relevant.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in